Chaim Lebovits
President & CEO · BRAINSTORM CELL THERAPEUTICS INC.
IndividualBuying only
- 2024
- May 29, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Chaim Lebovits's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Chaim Lebovits?
Chaim Lebovits is a corporate insider, tracked as President & CEO of BRAINSTORM CELL THERAPEUTICS INC. (BCLI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Chaim Lebovits last file a Form 4?
The most recent primary Form 4 on record is dated 29 May 2026, one of 2 filings going back to 2024.
Has Chaim Lebovits been buying or selling stock?
Recorded transactions: 2 open-market purchases ($11K) and 0 open-market sales across all tracked filings.
